Hair loss in three patients with acromegaly treated with octreotide [1]

British Journal of Dermatology

Volumn 149, Issue 3, 2003, Pages 655-656

  Lami, M C ^a   Hadjadj, S ^a   Guillet, G ^a  

^a Department of Dermatology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADENOMA; ADULT; AGED; ALOPECIA; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; HAIR LOSS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SOMATOTROPIC MACROADENOMA; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

ACROMEGALY; ADULT; AGED; ALOPECIA; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; HUMANS; MALE; OCTREOTIDE; PITUITARY NEOPLASMS;

EID: 0142025171     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05478.x     Document Type: Letter

References (5)

1. Brodin MB. Drug related alopecia. Dermatol Clin 1987; 5: 571-9.
2. Jönsson A, Manhem P. Octreotide and loss of scalp hair. Ann Intern Med 1991; 115: 913.
3. Nakauchi Y, Kumon Y, Yamasaki H et al. Scalp hair loss caused by octreotide in a patient with acromegaly: a case report. Endocr J 1995; 42: 385-9.
4. O'Keefe JDS, Peterson ME, Fleming CR. Octreotide as an adjunct to home parenteral nutrition in the management of permanent endojejunostomy syndrome. J Parenteral Enteral Nutr 1994; 18: 26-34.
5. Vecht J, Lamers CBHW, Masclee AAM. Long-term results of octreotide-therapy in severe dumping syndrome. Clin Endocrinol 1999; 51: 619-24.